Atlas Trials

A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus

Clinical trial NCT02040012 · UNKNOWN

Trial details

NCT number
NCT02040012
Sponsor
Alizé Pharma
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2013-07-01
Primary completion
2015-10-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.